News | Terumo

Randomized, Controlled, 500-Patient Trial Showed Patients Treated by Hydrogel Coils Less Likely to Have Adverse Outcomes than those Treated by Standard Bare Platinum Coils; Data Presented at International Stroke Conference 2017

March 06, 2017

Corporate

Terumo and Toxikon Europe NV announce a strategic partnershipby joining the expertise of both companies to service the pharmaceutical industry

February 16, 2017

Financial

Notice Concerning Completion of Sale of Shares Held by Terumo Corporation (PDF 84.89 KB)

February 10, 2017

Financial

Notice Concerning Acquisition Results of the Company's Own Shares through Off-Auction Own Share Repurchase Trading (ToSTNeT-3) (PDF 92.72 KB)

February 09, 2017

Financial

Notice Concerning Fixing the Repurchase Price through Off-Auction Own Share Repurchase Trading (ToSTNeT-3) (PDF 129.08 KB)

February 09, 2017

Financial

Notice Concerning Acquisition of the Company's Own Shares through Off-Auction Own Share Repurchase Trading (ToSTNeT-3) (PDF 143.21 KB)

February 09, 2017

Financial

Notice Concerning Sale of Shares Held by Terumo Corporation (PDF 66.74 KB)

February 09, 2017

Corporate

Terumo Announces Change of Executive Officers (PDF 135.55 KB)

February 09, 2017

Corporate

Terumo Announces Change of Representative Directors (PDF 131.95 KB)

January 31, 2017

Corporate

Terumo Opens a Branch in Yangon

Aiming to Contribute to the Development of Medical Technologies in Myanmar

January 30, 2017

Corporate

Terumo launches user friendly PLAJEX™ Luer Lock with Threaded Closure (TC)

January 26, 2017

Corporate

Terumo and Nemera announce compatibility between PLAJEX™ polymer prefillable syringes and Safe'n'Sound®

To serve the needs of the pharmaceutical industry and users, Terumo and Nemera agreed to cooperate. This to confirm compatibility between PLAJEX™ COP prefillable syringes and the Safe'n'Sound® platform, an add-on passive sharps injury protection device fo

January 21, 2017

Corporate

Terumo Completes Acquisition of Vascular Closure Business and Other Assets of Abbott and St. Jude Medical

Enhancing Company Offerings in the Interventional Access Device Business

January 19, 2017

Corporate

Terumo Acquires Bolton to Accelerate Growth of Its Vascular Graft Business

December 15, 2016

Corporate

Notice Regarding New Management Team (PDF 69.71 KB)

December 12, 2016

Financial

Terumo Formulates 5-Year Mid- to Long-term Growth Strategy-Aim to Expand in a Ten-Year Perspective as a Global Corporation with Japanese Origins

December 07, 2016

Corporate

Terumo Signs to Acquire Vascular Closure Business and Other Assets of St. Jude Medical and Abbott-Enhancing Company Offerings in the Interventional Access Device Business- (PDF 92.94 KB)

November 10, 2016

Financial

Notice Concerning Adoption of International Financial Reporting Standards (IFRS) (PDF 68.1 KB)

October 18, 2016

Corporate

Terumo to Acquire Portion of Vascular Closure Portfolio and Other Assets of St. Jude Medical and Abbott

August 25, 2016

Financial

Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 83.81 KB)

August 04, 2016

Financial

Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 111.47 KB)

June 24, 2016

Financial

Notice regarding the appointment of Independent Committee Members for the "Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures" (PDF 104.36 KB)

June 24, 2016

Corporate

Terumo Announces Voting Results for the Election of Directors (PDF 36.14 KB)

June 14, 2016

Corporate

Terumo Acquires Sequent Medical, U.S.-based Developer of New Aneurysm Embolization Device-Accelerating Growth in Neurovascular Treatment-

June 10, 2016

Corporate

FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility

June 06, 2016

Corporate

Terumo Launches HeartSheet®: A Global First Cellular and Tissue-based Product Designed for the Treatment of Heart Failure

May 18, 2016

Corporate

Major new study investigating abbreviated DAPT post-stent in high bleeding risk patients announced

Global study involving 4,300 patients from 34 countries announced at EuroPCR

May 10, 2016

Corporate

Terumo Appoints the Candidates for Directors (PDF 35.05 KB)

May 02, 2016

Corporate

Life-Saving Device Brings Eighth Queen's Award

- 1,400 patients' lives saved worldwide thanks to pioneering medical implant -
- Vascutek's device saves hospital providers an estimated £26,000 per operation -

April 18, 2016

Corporate

Terumo Institutes the "Terumo Fellow" Program

March 25, 2016

Financial

Notice Concerning Results and Completion of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 14.74 KB)

March 04, 2016

Financial

Notice Concerning the Status of Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 63.88 KB)

March 04, 2016

Corporate

Terumo's MEDISAFE Fit Smile, a Blood Glucose Meter, Receives an iF Design Award 2016